Even during my university days, I would find myself grasping my chest, wheezing after a short 15-minute walk to campus. In terms of fitness, I would consider myself to…
Pharmaceuticals
In this episode, we revisit Valeo Pharma (VPH.C) to get an update on their product portfolio, stock price, and financials. Is VPH.C a good long term investment? Tune In!…
Valeo Pharma (VPH.C) is a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Valeo Pharma (VPH.C) is a specialty pharmaceutical company that sources, acquires, or in-licenses brand and generic products for sale in Canada. Valeo’s business objective is to become an anchor…
Jody catches up with the CEO of Valeo Pharma (VPH.C), Steve Saviuk, to talk more about their specialty product. Redesca, and Asthma products, Enerzair® breezhaler® and Atectura® breezhaler®. Based…
The World Health Organization (WHO) has listed depression as a leading cause of disability worldwide and a major contributor to the overall global burden of disease. Unfortunately, traditional treatments…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and…
Last week, I was asked at least a dozen times by market professionals, “What sector do you like right now?” Normally that’s an easy question to ask as there’s…